104 related articles for article (PubMed ID: 3970725)
1. Amelioration of cyclosporin-induced nephrotoxicity in rats by induction of hepatic drug metabolism.
Cunningham C; Burke MD; Wheatley DN; Thomson AW; Simpson JG; Whiting PH
Biochem Pharmacol; 1985 Feb; 34(4):573-8. PubMed ID: 3970725
[TBL] [Abstract][Full Text] [Related]
2. The role of drug metabolism in cyclosporine A nephrotoxicity.
Burke MD; Whiting PH
Clin Nephrol; 1986; 25 Suppl 1():S111-6. PubMed ID: 3708920
[TBL] [Abstract][Full Text] [Related]
3. Influence of the hepatic drug-metabolizing enzyme-inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted rats.
Duncan JI; Heys SD; Thomson AW; Simpson JG; Whiting PH
Transplantation; 1988 Apr; 45(4):693-7. PubMed ID: 3282350
[TBL] [Abstract][Full Text] [Related]
4. Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity.
Cunningham C; Gavin MP; Whiting PH; Burke MD; Macintyre F; Thomson AW; Simpson JG
Biochem Pharmacol; 1984 Sep; 33(18):2857-61. PubMed ID: 6477645
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity.
McAuley FT; Simpson JG; Thomson AW; Whiting PH
Agents Actions; 1987 Jun; 21(1-2):209-16. PubMed ID: 3307341
[TBL] [Abstract][Full Text] [Related]
6. Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.
Whiting PH; Barnard N; Neilsch A; Simpson JG; Burke MD
Br J Exp Pathol; 1987 Dec; 68(6):777-86. PubMed ID: 3426946
[TBL] [Abstract][Full Text] [Related]
7. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
[TBL] [Abstract][Full Text] [Related]
8. [Effects of verapamil on cyclosporine. A (CsA)-induced nephropathy in ischemic kidney model in rats: changes in systemic hemodynamics and hepatic and renal microsomal cytochrome P-450].
Kishimoto T; Tsujino T; Nakatani T; Kim T; Ohyama A; Yoshimura R; Sakamoto W; Maekawa T; Kawashima H; Kusunose E
Hinyokika Kiyo; 1991 Oct; 37(10):1159-64. PubMed ID: 1755405
[TBL] [Abstract][Full Text] [Related]
9. Experimental cyclosporin A nephrotoxicity.
Whiting PH; Thomson AW; Blair JT; Simpson JG
Br J Exp Pathol; 1982 Feb; 63(1):88-94. PubMed ID: 7066186
[TBL] [Abstract][Full Text] [Related]
10. Lithium clearance measurements as an indication of cyclosporin A nephrotoxicity in the rat.
Whiting PH; Simpson JG
Clin Sci (Lond); 1988 Feb; 74(2):173-8. PubMed ID: 3338261
[TBL] [Abstract][Full Text] [Related]
11. Alleviation of experimental cyclosporin A toxicity by substitution of fish muscle oil as drug vehicle.
Craighead IB; Heys SD; Smart LM; Thomson AW; Whiting PH
Immunopharmacology; 1990; 20(1):21-9. PubMed ID: 2228568
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine and renal enzyme excretion.
Whiting PH; Thomson AW; Simpson JG
Clin Nephrol; 1986; 25 Suppl 1():S100-4. PubMed ID: 2871955
[TBL] [Abstract][Full Text] [Related]
13. The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat.
Augustine JA; Zemaitis MA
Drug Metab Dispos; 1986; 14(1):73-8. PubMed ID: 2868869
[TBL] [Abstract][Full Text] [Related]
14. Alterations in proteolytic enzymes of the proximal tubule in a rat model of cyclosporine nephrotoxicity.
Olbricht CJ; Gröne HJ; Bossaller C; Gutjahr E; Hertel RF
Transplantation; 1990 Sep; 50(3):378-81. PubMed ID: 2402785
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
[TBL] [Abstract][Full Text] [Related]
16. Effect of enzyme induction on Sandimmun (cyclosporin A) biotransformation and hepatotoxicity in cultured rat hepatocytes and in vivo.
Bouis P; Brouillard JF; Fischer V; Donatsch P; Boelsterli UA
Biochem Pharmacol; 1990 Jan; 39(2):257-66. PubMed ID: 2105730
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine nephrotoxicity in the Fischer rat.
Verani R
Clin Nephrol; 1986; 25 Suppl 1():S9-13. PubMed ID: 3708942
[TBL] [Abstract][Full Text] [Related]
18. The effect of silibinin on experimental cyclosporine nephrotoxicity.
Zima T; Kameníková L; Janebová M; Buchar E; Crkovská J; Tesar V
Ren Fail; 1998 May; 20(3):471-9. PubMed ID: 9606735
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes.
Clark MA; Bing BA; Gottschall PE; Williams JF
Biochem Pharmacol; 1995 Jan; 49(1):97-104. PubMed ID: 7840789
[TBL] [Abstract][Full Text] [Related]
20. Effect of fish oil treatment on gentamicin nephrotoxicity in rats.
Ali BH; Bashir AA
Ann Nutr Metab; 1994; 38(6):336-9. PubMed ID: 7702362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
